<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ye XL</submitter><funding>Natural Science Foundation of China</funding><funding>China Mega-project for Infectious Diseases</funding><funding>Peking University Medicine Fund of Fostering Young Scholars’ Scientific &amp;amp; Technological Innovation</funding><pagination>133</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8600349</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Severe fever with thrombocytopenia (SFTS) caused by SFTS virus (SFTSV) was a tick-borne hemorrhagic fever that posed significant threat to human health in Eastern Asia. The study was designed to measure the seroprevalence of SFTSV antibody in healthy population residing in a high endemic region.&lt;h4>Methods&lt;/h4>A cohort study was performed on healthy residents in Shangcheng County in Xinyang City from April to December in 2018, where the highest SFTS incidence in China was reported. Anti-SFTSV IgG was measured by indirect enzyme-linked immunosorbent assay and neutralizing antibody (NAb) was detected by using PRNT50. The logistic regression models were performed to analyze the variables that were associated with seropositive rates.&lt;h4>Results&lt;/h4>Totally 886 individuals we</pubmed_abstract><journal>Infectious diseases of poverty</journal><pubmed_title>Infection with severe fever with thrombocytopenia virus in healthy population: a cohort study in a high endemic region, China.</pubmed_title><pmcid>PMC8600349</pmcid><funding_grant_id>2018ZX10713002</funding_grant_id><funding_grant_id>2018ZX10301401</funding_grant_id><funding_grant_id>82073617</funding_grant_id><funding_grant_id>81825019</funding_grant_id><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Li JC</pubmed_authors><pubmed_authors>Cui N</pubmed_authors><pubmed_authors>Liu K</pubmed_authors><pubmed_authors>Fang LQ</pubmed_authors><pubmed_authors>Yang ZD</pubmed_authors><pubmed_authors>Zhang XA</pubmed_authors><pubmed_authors>Zhang JS</pubmed_authors><pubmed_authors>Lu QB</pubmed_authors><pubmed_authors>Liu W</pubmed_authors><pubmed_authors>Zhang HY</pubmed_authors><pubmed_authors>Yuan C</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Lv SM</pubmed_authors><pubmed_authors>Zhang PH</pubmed_authors><pubmed_authors>Huang YQ</pubmed_authors><pubmed_authors>Ye XL</pubmed_authors><pubmed_authors>Dai K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Infection with severe fever with thrombocytopenia virus in healthy population: a cohort study in a high endemic region, China.</name><description>&lt;h4>Background&lt;/h4>Severe fever with thrombocytopenia (SFTS) caused by SFTS virus (SFTSV) was a tick-borne hemorrhagic fever that posed significant threat to human health in Eastern Asia. The study was designed to measure the seroprevalence of SFTSV antibody in healthy population residing in a high endemic region.&lt;h4>Methods&lt;/h4>A cohort study was performed on healthy residents in Shangcheng County in Xinyang City from April to December in 2018, where the highest SFTS incidence in China was reported. Anti-SFTSV IgG was measured by indirect enzyme-linked immunosorbent assay and neutralizing antibody (NAb) was detected by using PRNT50. The logistic regression models were performed to analyze the variables that were associated with seropositive rates.&lt;h4>Results&lt;/h4>Totally 886 individuals we</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Nov</publication><modification>2025-04-18T13:27:22.702Z</modification><creation>2022-02-11T13:03:32.8Z</creation></dates><accession>S-EPMC8600349</accession><cross_references><pubmed>34794512</pubmed><doi>10.1186/s40249-021-00918-0</doi></cross_references></HashMap>